3-(2,2,2-trimethylhydrazine)propionate has been researched along with acetyl coenzyme a in 1 studies
| Studies (3-(2,2,2-trimethylhydrazine)propionate) | Trials (3-(2,2,2-trimethylhydrazine)propionate) | Recent Studies (post-2010) (3-(2,2,2-trimethylhydrazine)propionate) | Studies (acetyl coenzyme a) | Trials (acetyl coenzyme a) | Recent Studies (post-2010) (acetyl coenzyme a) |
|---|---|---|---|---|---|
| 251 | 35 | 105 | 3,551 | 14 | 1,291 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Shabanah, OA; Aleisa, AM; Darweesh, AQ; Fatani, AG; Rizwan, L; Sayed-Ahmed, MM | 1 |
1 other study(ies) available for 3-(2,2,2-trimethylhydrazine)propionate and acetyl coenzyme a
| Article | Year |
|---|---|
Carnitine deficiency aggravates cyclophosphamide-induced cardiotoxicity in rats.
Topics: Acetyl Coenzyme A; Adenosine Triphosphate; Animals; Antineoplastic Agents, Alkylating; Cardiomyopathies; Carnitine; Creatine Kinase, MB Form; Cyclophosphamide; Disease Models, Animal; L-Lactate Dehydrogenase; Male; Methylhydrazines; Rats; Rats, Wistar; Risk Factors | 2010 |